AI in Colorectal Cancer: From Patient Screening over Tailoring Treatment Decisions to Identification of Novel Biomarkers.

BACKGROUND

Artificial intelligence (AI) is increasingly entering and transforming not only medical research but also clinical practice. In the last ten years, new AI methods have enabled computers to perform visual tasks, reaching high performance, and thereby potentially supporting and even outperforming human experts. This is in particular relevant for colorectal cancer (CRC), which is the 3rd most common cancer type in general, as along the CRC patient journey many complex visual tasks need to be performed: from endoscopy over imaging to histopathology, the screening, diagnosis and treatment of CRC involve visual image analysis tasks.

SUMMARY

In all these clinical areas, AI models have shown promising results by supporting physicians, improving accuracy, and providing new biological insights and biomarkers. By predicting prognostic and predictive biomarkers from routine images/slides, AI models could lead to an improved patient stratification for precision oncology approaches in the near future. Moreover, it is conceivable that AI models, in particular together with innovative techniques such as single-cell or spatial profiling, could help to identify novel clinically as well as biologically meaningful biomarkers that could pave the way to new therapeutic approaches.

KEY MESSAGES

Here, we give a comprehensive overview of AI in colorectal cancer, describing and discussing these developments as well as the next steps which need to be taken to incorporate AI methods more broadly into the clinical care of CRC.

Informations de copyright

The Author(s). Published by S. Karger AG, Basel.